Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resistan
BACKGROUND: Acinetobacter baumannii infections are difficult to treat owing to the emergence of vari...
International audienceAim: To assess the effect of colistin-glycopeptide combination against a multi...
Objectives: The increased incidence of nosocomial infections by multidrug-resistant organisms has mo...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Nosocomial infection caused by Acinetobacter baumannii is endemic in hospital settings especially am...
Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial d...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
textMultidrug-resistant (MDR) Acinetobacter baumannii have caused nosocomial infections worldwide. N...
Yongyut Lertsrisatit,1 Wichai Santimaleeworagun,2,3 Sudaluck Thunyaharn,4 Jantima Traipattanakul5 1C...
ABSTRACT The alarming rise in antibiotic resistance has led to an increase in patient mortality and ...
Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main cau...
The spread of multidrug-resistant Acinetobacter baumannii (MDRAB) has led to the renaissance of coli...
BACKGROUND: Acinetobacter baumannii infections are difficult to treat owing to the emergence of vari...
International audienceAim: To assess the effect of colistin-glycopeptide combination against a multi...
Objectives: The increased incidence of nosocomial infections by multidrug-resistant organisms has mo...
Background: Colistin is being increasingly used for treatment of infections caused by multidrug-resi...
Nosocomial infection caused by Acinetobacter baumannii is endemic in hospital settings especially am...
Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial d...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
textMultidrug-resistant (MDR) Acinetobacter baumannii have caused nosocomial infections worldwide. N...
Yongyut Lertsrisatit,1 Wichai Santimaleeworagun,2,3 Sudaluck Thunyaharn,4 Jantima Traipattanakul5 1C...
ABSTRACT The alarming rise in antibiotic resistance has led to an increase in patient mortality and ...
Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of the main cau...
The spread of multidrug-resistant Acinetobacter baumannii (MDRAB) has led to the renaissance of coli...
BACKGROUND: Acinetobacter baumannii infections are difficult to treat owing to the emergence of vari...
International audienceAim: To assess the effect of colistin-glycopeptide combination against a multi...
Objectives: The increased incidence of nosocomial infections by multidrug-resistant organisms has mo...